Giordano D Beretta
Overview
Explore the profile of Giordano D Beretta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1043
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonanni P, Maio M, Beretta G, Icardi G, Rossi A, Cinieri S
Vaccines (Basel)
. 2024 Apr;
12(4).
PMID: 38675802
Patients with cancer can be immunocompromised because of their disease and/or due to anticancer therapy. In this population, severe influenza virus infections are associated with an elevated risk of morbidity...
2.
Cascinu S, Berardi R, Bianco R, Bilancia D, Zaniboni A, Ferrari D, et al.
Eur J Cancer
. 2021 Apr;
148:422-429.
PMID: 33812334
Background: The role of combination chemotherapy has not yet been established in unresectable locally advanced pancreatic cancer (LAPC) lacking dedicated randomized trials. Methods: This phase II trial tested the efficacy...
3.
Mansoor W, Arkenau H, Alsina M, Shitara K, Thuss-Patience P, Cuffe S, et al.
Gastric Cancer
. 2021 Mar;
24(4):970-977.
PMID: 33713215
Background: Patients with advanced gastroesophageal junction cancer (GEJC) have poor survival outcomes, and GEJC-specific data from trials evaluating agents in gastric cancers (GCs) as a whole are lacking. Trifluridine/tipiracil (FTD/TPI)...
4.
Salvatore L, Imperatori M, Arnoldi E, Carnaghi C, Cordio S, Cosimelli M, et al.
ESMO Open
. 2020 Dec;
5(6):e001001.
PMID: 33262200
About 75% of colorectal cancers are diagnosed as early stage, in which radical surgery is achievable. In the last decade, in Italy, the overall incidence of colorectal cancer has remained...
5.
Canziani L, Trovati S, Brunetta E, Testa A, De Santis M, Bombardieri E, et al.
J Autoimmun
. 2020 Jul;
114:102511.
PMID: 32713677
In cases of COVID-19 acute respiratory distress syndrome, an excessive host inflammatory response has been reported, with elevated serum interleukin-6 levels. In this multicenter retrospective cohort study we included adult...
6.
Ilson D, Tabernero J, Prokharau A, Arkenau H, Ghidini M, Fujitani K, et al.
JAMA Oncol
. 2019 Oct;
6(1):e193531.
PMID: 31600365
Importance: Trifluridine/tipiracil (FTD/TPI) treatment has shown clinical benefit in patients with pretreated metastatic gastric cancer or gastroesophageal junction cancer (mGC/GEJC). Patients who have undergone gastrectomy constitute a significant proportion of...
7.
Shitara K, Doi T, Dvorkin M, Mansoor W, Arkenau H, Prokharau A, et al.
Lancet Oncol
. 2018 Oct;
19(11):1437-1448.
PMID: 30355453
Background: Trifluridine/tipiracil showed activity and was well tolerated in a phase 2 study of pretreated patients with advanced gastric cancer done in Japan. We investigated whether the treatment was efficacious...
8.
Salvatore L, Aprile G, Arnoldi E, Aschele C, Carnaghi C, Cosimelli M, et al.
ESMO Open
. 2017 Aug;
2(1):e000147.
PMID: 28761730
In the past 15 years, the outcome for patients with metastatic colorectal cancer has substantially improved owing to the availability of new cytotoxic and biological agents along with many significant...
9.
Meriggi F, Codignola C, Beretta G, Ceresoli G, Caprioli A, Scartozzi M, et al.
Tumori
. 2017 Jul;
103(5):443-448.
PMID: 28731495
Purpose: Lung cancer is one of the leading causes of cancer-related death worldwide and, although targeted therapy with tyrosine kinase inhibitors has dramatically improved the rates of response and survival...
10.
Labianca R, Beretta G, Kildani B, Milesi L, Merlin F, Mosconi S, et al.
Crit Rev Oncol Hematol
. 2010 Feb;
74(2):106-33.
PMID: 20138539
Colon cancer is one of the leading tumours in the world and it is considered among the big killers, together with lung, prostate and breast cancer. In the recent years...